University of Maryland School of Medicine Greenebaum Comprehensive

22 South Greene Street
Baltimore, Maryland 21201

We've found

1 trials

at this facility

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!